Effect of 24 Weeks of Statin Therapy on Systemic and Vascular Inflammation in HIV-Infected Subjects Receiving Antiretroviral Therapy

Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals

(2013) CT Longenecker et al.   HIV MEDICINE

Systemic Effects of Inflammation on Health during Chronic HIV Infection

(2013) Steven G. Deeks et al.   IMMUNITY

Simvastatin Reduces Expression and Activity of Lipoprotein-Associated Phospholipase A2 in the Aorta of Hypercholesterolaemic Atherosclerotic Rabbits

(2013) Z Qiao et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease

(2012) Jennifer E. Ho et al.   AIDS

Elevated D-dimer is independently associated with endothelial dysfunction: a cross-sectional study in HIV-infected adults on antiretroviral therapy

(2012) Corrilynn O Hileman et al.   ANTIVIRAL THERAPY

Lipoprotein-associated phospholipase A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarker

(2012) Oana Vittos et al.   BIOMARKERS

Relationship of Lipoprotein-Associated Phospholipase A2 Mass and Activity with Incident Vascular Events among Primary Prevention Patients Allocated to Placebo or to Statin Therapy: An Analysis from the JUPITER Trial

(2012) P. M. Ridker et al.   CLINICAL CHEMISTRY

Statin Therapy Decreases Serum Levels of High-Sensitivity C-Reactive Protein and Tumor Necrosis Factor-α in HIV-Infected Patients Treated With Ritonavir-Boosted Protease Inhibitors

(2012) Leonardo Calza et al.   HIV CLINICAL TRIALS

Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals

(2012) Daniel A. Duprez et al.   PLoS One

Hyperlipidemia as an Instigator of Inflammation: Inaugurating New Approaches to Vascular Prevention

(2012) Paul M Ridker   Journal of the American Heart Association

Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome

(2011) Tomotaka Dohi et al.   ATHEROSCLEROSIS

The Effects of Statin Monotherapy and Low-Dose Statin/Ezetimibe on Lipoprotein-Associated Phospholipase A2

(2011) Sang-Hak Lee et al.   CLINICAL CARDIOLOGY

T Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in HIV-Infected Women

(2011) Robert C. Kaplan et al.   JOURNAL OF INFECTIOUS DISEASES

Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals

(2010) Jennifer E Ho et al.   AIDS

Low CD4+T Cell Count Is a Risk Factor for Cardiovascular Disease Events in the HIV Outpatient Study

(2010) Kenneth A. Lichtenstein et al.   CLINICAL INFECTIOUS DISEASES

Lp-PLA2: A New Target for Statin Therapy

(2010) Lynne T. Braun et al.   Current Atherosclerosis Reports

Association of Immunologic and Virologic Factors With Myocardial Infarction Rates in a US Healthcare System

(2010) Virginia A Triant et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Simvastatin Reduces Lipoprotein-associated Phospholipase A2 in Lipopolysaccharide-stimulated Human Monocyte–derived Macrophages Through Inhibition of the Mevalonate–Geranylgeranyl Pyrophosphate–RhoA-p38 Mitogen-activated Protein Kinase Pathway

(2010) Jun-Xian Song et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults

(2010) Philip Greenland et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

(2010)   LANCET

Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study

(2009) Carl Grunfeld et al.   AIDS

Relationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima‐Media Thickness in HIV‐Infected Patients Receiving Antiretroviral Therapy

(2009) Allison C. Ross et al.   CLINICAL INFECTIOUS DISEASES

Association of C-Reactive Protein and HIV Infection With Acute Myocardial Infarction

(2009) Virginia A Triant et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

(2009) Paul M Ridker et al.   LANCET

Consensus Panel Recommendation for Incorporating Lipoprotein-Associated Phospholipase A2 Testing into Cardiovascular Disease Risk Assessment Guidelines

(2008) Michael H. Davidson et al.   AMERICAN JOURNAL OF CARDIOLOGY

The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis

(2008) A. Blum et al.   ATHEROSCLEROSIS

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection

(2008) Lewis H Kuller et al.   PLOS MEDICINE